knee osteoarthritis Clinical Trials and Research
Also known as: knee oa, degenerative knee joint disease, arthritis of the knee, gonarthrosis, wear and tear arthritis · ICD-10: M17
Knee osteoarthritis is a common condition where the protective cartilage in the knee joint gradually wears away, leading to pain, stiffness, and reduced mobility. Clinical trial research is focused on developing new ways to manage symptoms, slow disease progression, and improve quality of life. Find a Trial helps patients search for active studies.
Search knee osteoarthritis trials →
Common questions about knee osteoarthritis clinical trials
What are common eligibility requirements for knee osteoarthritis clinical trials?
Eligibility often includes a confirmed diagnosis of knee osteoarthritis, specific pain levels, and certain age ranges. Some studies may require participants to have tried and failed previous treatments. Criteria vary by study, as seen on ClinicalTrials.gov.
What do the different phases of clinical trials mean for knee osteoarthritis research?
Early phases (1 and 2) test new treatments for safety and initial effectiveness in small groups. Later phases (3 and 4) involve larger groups to confirm efficacy, monitor side effects, and compare new treatments to existing ones. This process ensures thorough evaluation, according to NIH RePORTER data.
Do clinical trials for knee osteoarthritis cost money to participate in?
Generally, participants do not pay for study-related treatments, tests, or doctor visits. The trial sponsor usually covers these costs. However, travel or other personal expenses might not be reimbursed, so it's important to clarify with the study team.
What are some active research directions in knee osteoarthritis clinical trials?
Current research explores novel pain management strategies, regenerative medicine approaches like stem cell therapies, and disease-modifying osteoarthritis drugs (DMOADs) to slow cartilage degradation. Studies also investigate non-pharmacological interventions, as documented on ClinicalTrials.gov.
What types of interventions are commonly studied in knee osteoarthritis trials?
Interventions include new oral medications, injectable therapies (e.g., corticosteroids, hyaluronic acid, PRP), physical therapy regimens, and surgical techniques. Some trials also investigate devices or lifestyle modifications. Details are available on ClinicalTrials.gov and NIH RePORTER.
Are there specific biomarkers being studied in knee osteoarthritis research?
Yes, researchers are investigating biomarkers in blood, urine, and joint fluid that could indicate disease progression or treatment response. These include markers of cartilage breakdown, inflammation, and bone turnover. Such research aims to personalize treatment, according to NIH RePORTER.
What are common reasons someone might be excluded from a knee osteoarthritis clinical trial?
Common exclusion criteria might include severe co-existing medical conditions, recent knee surgery, certain medications, or other forms of arthritis. Pregnancy or breastfeeding are also often exclusion factors. Specific criteria vary by study protocol, as seen on ClinicalTrials.gov.
What outcomes do researchers typically measure in knee osteoarthritis trials?
Researchers commonly measure pain levels, physical function (e.g., walking, stair climbing), joint stiffness, and quality of life. Imaging changes, such as cartilage volume or bone marrow lesions, are also often assessed. These measures help evaluate treatment effectiveness, per ClinicalTrials.gov.
How to find a knee osteoarthritis trial that fits you
- Describe your knee osteoarthritis situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all knee osteoarthritis trials →